Literature DB >> 32147244

Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls.

Dejan Jakimovski1, Niels Bergsland2, Michael G Dwyer1, Jesper Hagemeier1, Deepa P Ramasamy1, Kinga Szigeti3, Thomas Guttuso3, David Lichter3, David Hojnacki4, Bianca Weinstock-Guttman4, Ralph H B Benedict4, Robert Zivadinov5.   

Abstract

Multiple sclerosis (MS) exhibits neurodegeneration driven disability progression. We compared the extent of neurodegeneration among 112 long-standing MS patients, 37 Parkinson's disease (PD) patients, 34 amnestic mild cognitive impairment (aMCI) patients, 37 Alzheimer's disease (AD) patients, and 184 healthy controls. 3T MRI volumes of whole brain (WBV), white matter (WMV), gray matter (GMV), cortical (CV), deep gray matter (DGM), and nuclei-specific volumes of thalamus, caudate, putamen, globus pallidus, and hippocampus were derived with SIENAX and FIRST software. Аge and sex-adjusted analysis of covariance was used. WBV was not significantly different between diseases. MS had significantly lower WMV compared to other disease groups (p < 0.021). Only AD had smaller GMV and CV when compared to MS (both p < 0.001). MS had smaller DGM volume than PD and aMCI (p < 0.001 and p = 0.026, respectively) and lower thalamic volume when compared to all other neurodegenerative diseases (p < 0.008). Long-standing MS exhibits comparable global atrophy with lower WMV and thalamic volume when compared to other classical neurodegenerative diseases.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Deep gray matter; MRI; Multiple sclerosis; Neurodegeneration; Parkinson’s disease; Thalamus; Whole brain atrophy

Mesh:

Year:  2020        PMID: 32147244      PMCID: PMC7166193          DOI: 10.1016/j.neurobiolaging.2020.02.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  46 in total

1.  Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease.

Authors:  J H Xuereb; R H Perry; J M Candy; E K Perry; E Marshall; J R Bonham
Journal:  Brain       Date:  1991-06       Impact factor: 13.501

2.  Altered nuclei-specific thalamic functional connectivity patterns in multiple sclerosis and their associations with fatigue and cognition.

Authors:  Fuchun Lin; Robert Zivadinov; Jesper Hagemeier; Bianca Weinstock-Guttman; Caila Vaughn; Sirin Gandhi; Dejan Jakimovski; Hanneke E Hulst; Ralph Hb Benedict; Niels Bergsland; Tom Fuchs; Michael G Dwyer
Journal:  Mult Scler       Date:  2018-07-13       Impact factor: 6.312

3.  What drives MRI-measured cortical atrophy in multiple sclerosis?

Authors:  V Popescu; R Klaver; P Voorn; Y Galis-de Graaf; D L Knol; J W R Twisk; A Versteeg; G J Schenk; P Van der Valk; F Barkhof; H E De Vries; H Vrenken; J J G Geurts
Journal:  Mult Scler       Date:  2015-01-12       Impact factor: 6.312

4.  The nature of verbal memory impairment in multiple sclerosis: a list-learning and meta-analytic study.

Authors:  Jose M Lafosse; Sandra M Mitchell; John R Corboy; Christopher M Filley
Journal:  J Int Neuropsychol Soc       Date:  2013-10       Impact factor: 2.892

5.  Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.

Authors:  Kelvin K Leung; Jonathan W Bartlett; Josephine Barnes; Emily N Manning; Sebastien Ourselin; Nick C Fox
Journal:  Neurology       Date:  2013-01-09       Impact factor: 9.910

Review 6.  Epidemiology and treatment of multiple sclerosis in elderly populations.

Authors:  Caila B Vaughn; Dejan Jakimovski; Katelyn S Kavak; Murali Ramanathan; Ralph H B Benedict; Robert Zivadinov; Bianca Weinstock-Guttman
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

7.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

8.  A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.

Authors:  N Grytten; J H Aarseth; H M B Lunde; K M Myhr
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-24       Impact factor: 10.154

9.  Long-term evolution of multiple sclerosis disability in the treatment era.

Authors:  Bruce A C Cree; Pierre-Antoine Gourraud; Jorge R Oksenberg; Carolyn Bevan; Elizabeth Crabtree-Hartman; Jeffrey M Gelfand; Douglas S Goodin; Jennifer Graves; Ari J Green; Ellen Mowry; Darin T Okuda; Daniel Pelletier; H-Christian von Büdingen; Scott S Zamvil; Alisha Agrawal; Stacy Caillier; Caroline Ciocca; Refujia Gomez; Rachel Kanner; Robin Lincoln; Antoine Lizee; Pamela Qualley; Adam Santaniello; Leena Suleiman; Monica Bucci; Valentina Panara; Nico Papinutto; William A Stern; Alyssa H Zhu; Gary R Cutter; Sergio Baranzini; Roland G Henry; Stephen L Hauser
Journal:  Ann Neurol       Date:  2016-08-13       Impact factor: 10.422

10.  Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.

Authors:  Elijah Mak; Li Su; Guy B Williams; Michael J Firbank; Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Brit Mollenhauer; Adrian M Owen; Tien K Khoo; David J Brooks; James B Rowe; Roger A Barker; David J Burn; John T O'Brien
Journal:  Neurobiol Aging       Date:  2017-03-16       Impact factor: 4.673

View more
  3 in total

1.  Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?

Authors:  Dejan Jakimovski; Ralph H B Benedict; Bianca Weinstock-Guttman; Osman Ozel; Tom A Fuchs; Norah Lincoff; Niels Bergsland; Michael G Dwyer; Robert Zivadinov
Journal:  J Neurol       Date:  2021-02-15       Impact factor: 4.849

Review 2.  Cognitive Decline in Older People with Multiple Sclerosis-A Narrative Review of the Literature.

Authors:  Hsueh-Sheng Chiang; Alka Khera; Barbara E Stopschinski; Olaf Stuve; John Hart; Brendan Kelley; Trung Nguyen
Journal:  Geriatrics (Basel)       Date:  2022-06-05

3.  A Hybrid Approach for MS Diagnosis Through Nonlinear EEG Descriptors and Metaheuristic Optimized Classification Learning.

Authors:  Elnaz Mohseni; Seyed Mahdi Moghaddasi
Journal:  Comput Intell Neurosci       Date:  2022-05-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.